🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Safety of Sedation During Interventional Endoscopy

Recruitingn/aAges 18 Years - anyAllMedical University Innsbruck
NCT07872657 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Sedation is routinely used during interventional endoscopic procedures to improve patient comfort and optimize procedural conditions. Non-anaesthesiologist-administered propofol sedation (NAPS) has been demonstrated to be safe and effective for many endoscopic procedures, including complex interventions such as endoscopic retrograde cholangiopancreatography (ERCP). However, evidence supporting its use during technically demanding or prolonged procedures and in patients with severe comorbidities (ASA class ≥ III) remains limited. At our institution, interventional endoscopic procedures have been routinely performed for many years using standardized NAPS protocols, including in higher-risk patients, with comprehensive staff training, continuous patient monitoring, supplemental oxygen administration, and immediate access to an emergency response team. This non-interventional observational

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Patients ≥18 years of age at time of consent 2. Ability to understand and willingness to sign and date written informed consent document 3. Patients who undergo an interventional endoscopic procedure at Innsbruck University Hospital (ERCP, interventional EUS, interventional EGD). Exclusion Criteria: 1. Pregnancy 2. Inability to consent 3. Respiratory instability before start of intervention (SpO2 \<90 %) 4. Oxygen treatment via nasal cannula \>3 l/min before start of intervention 5. Hemodynamic instability before start of intervention (MAP \< 65 mmHg and/or vasopressor/catecholamine therapy and/or heart rate \<50/min)
💊

What it tests

  • Sedation during interventional endoscopy
📍

Where

1 site
Medical University of Innsbruck
Innsbruck, Austria
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy